CN104117003A - Chinese herba preparation for treating arrhythmia - Google Patents
Chinese herba preparation for treating arrhythmia Download PDFInfo
- Publication number
- CN104117003A CN104117003A CN201410399251.1A CN201410399251A CN104117003A CN 104117003 A CN104117003 A CN 104117003A CN 201410399251 A CN201410399251 A CN 201410399251A CN 104117003 A CN104117003 A CN 104117003A
- Authority
- CN
- China
- Prior art keywords
- chinese
- preparation
- fructus
- crude drug
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herba preparation for treating arrhythmia. The Chinese herba preparation is prepared from the following traditional Chinese medicinal materials by weight: 30-60g of corn stigma, 30-60g of Chinese elder herb roots, 5-11g of feather cockscomb seeds, 3-11g of radix clematidis, 3-9g of rhizoma osmundae, 3-9g of elettaria cardamomum, 3-9g of juncus communis, 2-8g of beautiful sweetgum fruits and 1-5g of negundo chastetree fruits. The Chinese herba preparation has the advantages that the used traditional Chinese medicinal materials meet the pharmacopoeia of the People's Republic of China; the preparation is safe and reliable in medicines, safe to use and has no toxic and side effects; for arrhythmia, the Chinese herba preparation is quick in response and has significant curative effect.
Description
Technical field
The present invention relates to technical field of Chinese medicines, specifically refer to a kind of ARR Chinese medicine preparation for the treatment of.
Background technology
Arrhythmia is because sinuatrial node is exciting abnormal or excitement results from beyond sinuatrial node, exciting conduction slowly, retardance or through abnormal passage conduction, the origin of cardiomotility and (or) conductive impairment cause frequency and (or) the allorhythmia of heartbeat.The ecg characteristics of sinus rhythm is: P ripple rule occurs, and P waveform state shows exciting from sinuatrial node (be P ripple upright in I, II, aVF, V4~V6, be inverted at aVR).The frequency of normal sinus rhythm is generally 60 ~ 100 beats/min.During clinically by arrhythmia episode, the speed of heart rate is divided into rapidity and the large class of bradyarrhythmia two, and the former sees premature beat, tachycardia, atrial fibrillation and ventricular fibrillation etc., and adult's heart rate surpasses 100 beats/min for overrunning; The latter be take sinus bradycardia and various conduction block as common, and heart rate is excessively slow, lower than 60 beats/min, has a strong impact on the blood supply of the main organs such as the heart, brain and occurs the symptoms such as giddy, dim eyesight.Arrhythmia is one group of disease important in cardiovascular disease.It can be fallen ill separately and also can occur together with cardiovascular diseases.
ARR making a definite diagnosis mostly will be leaned on electrocardiogram, and some patients were can be made tentative diagnosis according to medical history and sign.Question closely in detail when outbreak heart rate, the rhythm and pace of moving things whether (rule, leak the sense etc. of fighting), outbreak start-stop and persistent period.During outbreak, have or not the performances such as hypotension, faintness or intimate faintness, tic, angina pectoris or heart failure, and inducement, frequency and the treatment process of previously outbreak, contribute to judge arrhythmia.
ARR pathogenic factor is very complicated, also varied to its treatment.For different pathogeny, have at present by the Western medicine such as isoproterenol, atropine and increase autorhythmia of cardiac and (or) accelerate conduction, have by non-drug therapy treatments such as cardiac pacemaker, electric defibrillation, radio-frequency (RF) ablation.Long-term taking anti-arrhythmic all has side effect in various degree, serious caused ventricular arrhythmia or heart block and fatal.Therefore, during clinical practice, should strictly grasp indication, note untoward reaction, so that emergent at any time.
Summary of the invention
The object of the invention is exactly in order to make up the defect of prior art, provide a kind of instant effect, evident in efficacy, make
With safely, the ARR Chinese medicine preparation for the treatment of that has no side effect.The present invention is achieved by the following technical solutions:
Treat an ARR Chinese medicine preparation, by the Chinese crude drug of following weight, made: Stigma Maydis 30 ~ 60g, Radix Sambuci Chiensis 30 ~ 60g, Semen Celosiae 5 ~ 11g, Radix Clematidis 3 ~ 11g, Rhizoma Osmundae Japonicae 3 ~ 9g, Fructus Amomi Rotundus 3 ~ 9g, Medulla Junci 3 ~ 9g, Fructus Liquidambaris 2 ~ 8g, Fructus Viticis Negundo 1 ~ 5g.
Preferably, a kind ofly treat ARR Chinese medicine preparation, by the Chinese crude drug of following weight, made: Stigma Maydis 45g, Radix Sambuci Chiensis 45g, Semen Celosiae 7g, Radix Clematidis 7g, Rhizoma Osmundae Japonicae 6g, Fructus Amomi Rotundus 6g, Medulla Junci 6g, Fructus Liquidambaris 5g, Fructus Viticis Negundo 3g.
The preparation method of the ARR Chinese medicine preparation of above-mentioned treatment is: the Chinese crude drug that takes described weight is put into drug-decocting appliance, adds 3000 milliliters of pure water; Soak at room temperature 1 hour, makes Chinese crude drug fully moistening, fully fried in order to medicine juice; Boil with high heat and use again slow fire instead and decoct 1 hour, remove by filter medicinal residues, filtrate is concentrated into 500 milliliters and get final product.
Therapeutic Method: oral, one time 10 milliliters, sooner or later each once, is taken two months continuously.
The invention has the advantages that used Chinese crude drug meets Pharmacopoeia of People's Republic of China regulation, safety of medicine is reliable, and beneficial effect is compared to existing technology: treat ARR evident in efficacy, instant effect, use safely, have no side effect.
the specific embodiment:
Below in conjunction with embodiment and case, the present invention is further illustrated.
Embodiment 1:
Take Stigma Maydis 30g, Radix Sambuci Chiensis 60g, Semen Celosiae 5g, Radix Clematidis 11g, Rhizoma Osmundae Japonicae 3g, Fructus Amomi Rotundus 9g, Medulla Junci 3g, Fructus Liquidambaris 8g, Fructus Viticis Negundo 1g puts into drug-decocting appliance, adds 3000 milliliters of pure water; Soak at room temperature 1 hour, makes Chinese crude drug fully moistening, fully fried in order to medicine juice; Boil with high heat and use again slow fire instead and decoct 1 hour, remove by filter medicinal residues, filtrate is concentrated into 500 milliliters and obtains the ARR Chinese medicine preparation for the treatment of.
Embodiment 2:
Take Stigma Maydis 60g, Radix Sambuci Chiensis 30g, Semen Celosiae 11g, Radix Clematidis 3g, Rhizoma Osmundae Japonicae 9g, Fructus Amomi Rotundus 3g, Medulla Junci 9g, Fructus Liquidambaris 2g, Fructus Viticis Negundo 5g puts into drug-decocting appliance, adds 3000 milliliters of pure water; Soak at room temperature 1 hour, makes Chinese crude drug fully moistening, fully fried in order to medicine juice; Boil with high heat and use again slow fire instead and decoct 1 hour, remove by filter medicinal residues, filtrate is concentrated into 500 milliliters and obtains the ARR Chinese medicine preparation for the treatment of.
Embodiment 3:
Take Stigma Maydis 45g, Radix Sambuci Chiensis 45g, Semen Celosiae 7g, Radix Clematidis 7g, Rhizoma Osmundae Japonicae 6g, Fructus Amomi Rotundus 6g, Medulla Junci 6g, Fructus Liquidambaris 5g, Fructus Viticis Negundo 3g puts into drug-decocting appliance, adds 3000 milliliters of pure water; Soak at room temperature 1 hour, makes Chinese crude drug fully moistening, fully fried in order to medicine juice; Boil with high heat and use again slow fire instead and decoct 1 hour, remove by filter medicinal residues, filtrate is concentrated into 500 milliliters and obtains the ARR Chinese medicine preparation for the treatment of.
In order to check Chinese medicine preparation of the present invention to treat ARR effect, choose Liuan City, Anhui Province patients with arrhythmia 72 examples, 25 ~ 70 years old age, 51 years old mean age, male's 38 examples wherein, women's 34 examples.In above 72 routine rhythm abnormality patients; electrocardiogram prompting sinus bradycardia 12 examples; arrhythmia 14 examples; accidental atrial premature beat 7 examples, first degree A-V block 6 examples, sick sinus syndrome 10 examples; rapid atrial fibrillation 7 examples; paroxysmal supraventricular tachycardia 8 examples, sustained ventricular tachycardia 8 examples, patient's ubiquity chest pain, uncomfortable in chest, feel suffocated, the malaise symptoms such as palpitation and restlessness, weak, insomnia and dreamful sleep.All patients are divided into three treatment groups at random, each treatment group 24 example, wherein, treatment group 1 adopts the Chinese medicine preparation treatment of the embodiment of the present invention 1, the Chinese medicine preparation treatment that treatment group 2 adopts the embodiment of the present invention 2, the Chinese medicine preparation treatment that treatment group 3 adopts the embodiment of the present invention 3.
Therapeutic Method: oral, one time 10 milliliters, sooner or later each once, is taken two months continuously.During treatment, forbid other antiarrhythmic drugs.
Criterion of therapeutical effect:
Effective: ambulatory electrocardiogram recovers normal, chest pain, uncomfortable in chest, feel suffocated, the malaise symptoms such as palpitation and restlessness, weak, insomnia and dreamful sleep disappears or obviously alleviates.
Effective: ambulatory electrocardiogram is compared improvement with before treatment, chest pain, uncomfortable in chest, feel suffocated, the malaise symptoms such as palpitation and restlessness, weak, insomnia and dreamful sleep takes a turn for the better.
Invalid: ambulatory electrocardiogram is compared without any improvement with before treatment, chest pain, uncomfortable in chest, feel suffocated, the malaise symptoms such as palpitation and restlessness, weak, insomnia and dreamful sleep is without any improvement.
Therapeutic outcome:
? | Number | Effective | Effectively | Invalid | Obvious effective rate | Total effective rate |
Treatment group 1 | 24 | 11 | 13 | 0 | 45.8% | 100% |
Treatment group 2 | 24 | 15 | 9 | 0 | 62.5% | 100% |
Treatment group 3 | 24 | 20 | 4 | 0 | 83.3% | 100% |
In therapeutic process, all patient bodies all do not produce untoward reaction.
From above-mentioned therapeutic outcome, can find out, three prepared Chinese medicine preparation of embodiment of the present invention all have the curative effect of good treatment rhythm abnormality, and total effective rate reaches 100%, wherein, the obvious effective rate of the Chinese medicine preparation of embodiment 3 has reached 83.3%, is the ARR medicine of anti-wide spectrum safely and effectively.This is the beyond thought technique effect that the present invention obtains.
Claims (2)
1. the ARR Chinese medicine preparation for the treatment of, is characterized in that: the Chinese crude drug by following weight is made: Stigma Maydis 30 ~ 60g, Radix Sambuci Chiensis 30 ~ 60g, Semen Celosiae 5 ~ 11g, Radix Clematidis 3 ~ 11g, Rhizoma Osmundae Japonicae 3 ~ 9g, Fructus Amomi Rotundus 3 ~ 9g, Medulla Junci 3 ~ 9g, Fructus Liquidambaris 2 ~ 8g, Fructus Viticis Negundo 1 ~ 5g; Its preparation method is: the Chinese crude drug that takes described weight is put into drug-decocting appliance, adds 3000 milliliters of pure water; Soak at room temperature 1 hour, makes Chinese crude drug fully moistening, fully fried in order to medicine juice; Boil with high heat and use again slow fire instead and decoct 1 hour, remove by filter medicinal residues, filtrate is concentrated into 500 milliliters and get final product.
2. a kind of ARR Chinese medicine preparation for the treatment of according to claim 1, is characterized in that: the Chinese crude drug by following weight is made: Stigma Maydis 45g, Radix Sambuci Chiensis 45g, Semen Celosiae 7g, Radix Clematidis 7g, Rhizoma Osmundae Japonicae 6g, Fructus Amomi Rotundus 6g, Medulla Junci 6g, Fructus Liquidambaris 5g, Fructus Viticis Negundo 3g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410399251.1A CN104117003A (en) | 2014-08-14 | 2014-08-14 | Chinese herba preparation for treating arrhythmia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410399251.1A CN104117003A (en) | 2014-08-14 | 2014-08-14 | Chinese herba preparation for treating arrhythmia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104117003A true CN104117003A (en) | 2014-10-29 |
Family
ID=51762783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410399251.1A Withdrawn CN104117003A (en) | 2014-08-14 | 2014-08-14 | Chinese herba preparation for treating arrhythmia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104117003A (en) |
-
2014
- 2014-08-14 CN CN201410399251.1A patent/CN104117003A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104547939A (en) | Traditional Chinese medicine preparation for treating premature beat | |
Srivatsa et al. | Sarcoidosis and atrial fibrillation: a rare association and interlink with inflammation | |
CN104127556B (en) | One treats ARR Chinese medicine preparation | |
CN104138437B (en) | One is treated ARR Chinese medicine preparation | |
CN103536767B (en) | A kind of preparation method for the treatment of the medicament of cardiopalmus | |
CN104117003A (en) | Chinese herba preparation for treating arrhythmia | |
Hooqenhuvze et al. | Acute effects of intravenous amiodarone in patients with complex ventricular dysrhythmias | |
Holt et al. | Intravenous amiodarone; An effective anti-arrhythmic agent | |
CN104173881A (en) | Traditional Chinese medicine preparation for treating arrhythmia | |
CN104127734A (en) | Traditional Chinese medicine (TCM) preparation for treating arrhythmia | |
CN104173694A (en) | Traditional Chinese medicine preparation for treating arrhythmia | |
CN104096009A (en) | Traditional Chinese medicine preparation for treating arrhythmia | |
CN103800723B (en) | One is used for the treatment of ARR Chinese medicine composition and preparation method thereof | |
CN102284004B (en) | Medicament for treating arrhythmia | |
CN103566304B (en) | A kind of preparation method for the treatment of the pharmaceutical composition of cardiopalmus | |
CN102327566B (en) | Traditional Chinese medicine preparation for curing ventricular extrasystole | |
CN105395679A (en) | Traditional Chinese medicine preparation for treating stenocardia | |
CN103007200B (en) | Medicament for treating coronary heart disease | |
CN103169937B (en) | Drug for treating arrhythmia | |
CN115634243A (en) | Application of Shuanghuanglian in preparing medicine for treating arrhythmia caused by aconitine poisoning | |
CN102488853A (en) | Traditional Chinese medicine composition for treating arteriosclerosis | |
CN107625838A (en) | A kind of Chinese medicine preparation for treating cardiac arrhythmia and preparation method thereof | |
Ocak et al. | Is electrocardiography sufficient for supraventricular tachycardia treatment? A Case Report | |
Tokano et al. | Atrioventricular block during atrioventricular nodal reentrant tachycardia is not always benign | |
CN106511911A (en) | Traditional Chinese medicine patch for treating coronary heart disease and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20141029 |